help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rose, R. M.
Right arrow Articles by Furlong, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rose, R. M.
Right arrow Articles by Furlong, S. T.

Am. J. Respir. Crit. Care Med., Vol 149, No. 2, Feb 1994, 332-338.

Abnormal lipid composition of bronchoalveolar lavage fluid obtained from individuals with AIDS-related lung disease

RM Rose, PJ Catalano, H Koziel and ST Furlong
Division of Pulmonary and Critical Care Medicine, New England Deaconess Hospital, Boston, Massachusetts.

Surfactant lipids are not only important to the physiologic function of the lungs, but may also influence disease processes like Pneumocystis pneumonia, in which the interaction of host-defense cells with pathogen occurs within the confines of the surfactant-rich alveolar hypophase. In the present studies the lipid profile of bronchoalveolar lavage fluid (BALF) was characterized in subjects with AIDS-related lung diseases including Pneumocystis pneumonia. BALF lipid and total protein measurements were made in 43 subjects with acquired immune deficiency syndrome (AIDS)-related lung disease and compared with those made in 50 normal human immunodeficiency virus (HIV)-seronegative controls. The AIDS patient samples contained significantly greater amounts of total cholesterol, phosphatidylglycerol (PG), and protein than the control samples; in contrast to previous observations in rodent P. carinii infection, no differences were seen in total phospholipid (PL) or phosphatidylcholine (PC) in the two groups. The proportions of several of these lipids were deranged in BALF obtained from the patient group: PG/PL and PC/cholesterol differed significantly from normal samples. In the subset of patients with AIDS-related Pneumocystis pneumonia, no correlation was apparent between discrete BALF lipids and clinical indices reflective of disease severity. Using these measurements to approximate the lipid composition of the alveolar microenvironment in AIDS-related lung disease, we performed experiments in which normal human alveolar macrophages were exposed to exogenous liposomal lipids and then challenged with P. carinii. The ingestion but not binding of P. carinii by macrophages was diminished as a result of lipid exposure.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Z. Wang, A. Foye, Y. Chang, P. R. Chess, T. W. Wright, S. Bhagwat, F. Gigliotti, and R. H. Notter
Inhibition of surfactant activity by Pneumocystis carinii organisms and components in vitro
Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1124 - L1131.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. N. Atochina, M. F. Beers, S. T. Scanlon, A. M. Preston, and J. M. Beck
P. carinii induces selective alterations in component expression and biophysical activity of lung surfactant
Am J Physiol Lung Cell Mol Physiol, March 1, 2000; 278(3): L599 - L609.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
E. S. Kaneshiro
The Lipids of Pneumocystis carinii
Clin. Microbiol. Rev., January 1, 1998; 11(1): 27 - 41.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1994 American Thoracic Society